The 2007 and 2008 shingles and varicella vaccination recommendations may have contributed to the declining herpes zoster hospitalization rates in some groups.

In an effort to effectively address global health concerns, the WHO has announced the 13th General Programme of Work, a 5-year strategic plan spanning from 2019 to 2023.

Omadacycline is noninferior to moxifloxacin for community-acquired bacterial pneumonia and noninferior to linezolid for acute bacterial skin infections.

The FDA has announced a new plan to significantly modernize the regulation and oversight of dietary supplements.

Data collection included socio-demographic variables, comorbidities, treatment-related clinical events, immunosuppressant usage, concomitant treatment, and adjustments in dose or type of immunosuppressant.

These findings indicate age-specific treatment approaches would likely benefit patients with atopic dermatitis.

This systematic review was limited by literature that was lacking in survival analyses and inconsistent definitions of drug discontinuation across the literature.

Primary study outcomes were the development of alopecia areata in the cohort exposed to depression and the development of major depressive disorder in the cohort exposed to alopecia.

After 16 weeks of treatment with dupilumab, the median SCORAD score decreased 55%.

Hidradenitis suppurativa has a significant negative impact on patient quality of life, which has been reported to be greater than that of atopic eczema and psoriasis.